OSAKA--Nobel laureate Tasuku Honjo’s long-running dispute with Osaka-based Ono Pharmaceutical Co. for royalties following his discovery of the anti-cancer drug Opdivo has finally led to a ...
Nobel laureate Tasuku Honjo announced June 5 he is taking legal action against Ono Pharmaceutical Co. this month to seek 22.6 billion yen ($207 million) in patent royalties concerning the Opdivo ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback